PLoS GeneticsGenetic & Genomic MedicinePeer-reviewed journal article
Size matters: large copy number losses reveal novel Hirschsprung disease genes
Laura E. KuiliD, Katherine C. MacKenzieiD, Clara Sze-Man TangiD, Jonathan D. WindsteriD, Linh Thuy LeiD, Anwarul KarimiD, Bianca M. de GraafiD, Robert M. van der Helm, Yolande van BeveriD, Cornelius E. J. SlootsiD, Conny J. H. M. MeeusseniD, Dick TibboeliD, Annelies de KleiniD, Rene M. H. WijneniD, Jeanne AmieliD, Stanislas LyonnetiD, María-Mercé García-BarcelóiD, Paul Kwong Hang TamiD, Maria M. AlvesiD, Alice S. BrooksiD, Robert M.W. HofstraiD, Erwin BrosensiD
Abstract
BackgroundHirschsprung disease (HSCR) is characterized by absence of ganglia in the intestine. Approximately 18% of patients have additional anatomical malformations or neurological symptoms (HSCR-AAM). HSCR is a complex genetic disease in which the loss of enteric ganglia stems from a combination of genetic alterations: rare coding variants, predisposing haplotypes and Copy Number Variation (CNV). Pinpointing the responsible culprits within a large CNV is challenging as often many genes are affected. We investigated if we could find deleterious CNVs and if we could identify the genes responsible for the aganglionosis. ResultsDeleterious CNVs were detected in three groups of patients: HSCR-AAM, HSCR patients with a confirmed causal genetic variant and HSCR-isolated patients without a known causal variant and controls. Predisposing haplotypes were determined, confirming that every HSCR subgroup had increased contributions of predisposing haplotypes, but their contribution was highest in isolated HSCR patients without RET coding variants. CNV profiling proved that HSCR-AAM patients had larger copy number losses. Gene enrichment strategies using mouse enteric nervous system transcriptomes and constraint metrics were used to determine plausible candidate genes in Copy Number Losses. Validation in zebrafish using CRISPR/Cas9 targeting confirmed the contribution of UFD1L, TBX2, SLC8A1 and MAPK8 to ENS development. In addition, we revealed epistasis between reduced Ret and Gnl1 expression in vivo. ConclusionRare large Copy Number losses - often de novo - contribute to the disease in HSCR-AAM patients specifically. We proved the involvement of five genes in enteric nervous system development and Hirschsprung disease.
- organism: mouse
- organism: zebrafish
- assay: whole-genome sequencing
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: statistical model
- Citations
- 28
- FWCI
- 5.16
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Joint disruption of Ret and Ednrb transcription drives cell fate reversal in the Enteric Nervous System in Hirschsprung disease
Ryan D. Fine, Rebecca Chubaryov, … Aravinda Chakravarti·bioRxiv·Mar 4, 2025
- Combined effects of Ret coding and enhancer loss-of-function alleles cause progressive loss of inhibitory motor neurons in the enteric nervous system
Lauren E. Fries, Gabriel Grullon, … Sumantra Chatterjee·bioRxiv·Jan 23, 2025
- A multi-enhancer RET regulatory code is disrupted in Hirschsprung disease
Sumantra Chatterjee, Kameko M. Karasaki, … Aravinda Chakravarti·Genome ResearchPeer-reviewed·Dec 1, 2021
- Multiple, independent, common variants overlapping known and putative gut enhancers at RET, SEMA3 and NRG1 underlie Hirschsprung disease risk in European ancestry subjects
Ashish Kapoor, Priyanka Nandakumar, … Aravinda Chakravarti·Journal of Pediatric SurgeryPeer-reviewed·Dec 1, 2021
- The Role of de novo and Ultra-Rare Variants in Hirschsprung Disease (HSCR): Extended Gene Discovery for Risk Profiling of Patients
Mingzhou Fu, Hanna Berk-Rauch, … Aravinda Chakravarti·medRxiv·Jan 7, 2025
- RET enhancer haplotype-dependent remodeling of the human fetal gut development program
Sumantra Chatterjee, Lauren E. Fries, … Aravinda Chakravarti·PLoS GeneticsPeer-reviewed·Nov 10, 2023